• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过虚拟筛选方法识别针对耐氯喹恶性疟原虫的β-血红素形成抑制剂。

Identifying inhibitors of β-haematin formation with activity against chloroquine-resistant Plasmodium falciparum malaria parasites via virtual screening approaches.

机构信息

Department of Chemistry, University of Cape Town, Rondebosch, 7701, South Africa.

Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Rondebosch, 7701, South Africa.

出版信息

Sci Rep. 2023 Feb 14;13(1):2648. doi: 10.1038/s41598-023-29273-w.

DOI:10.1038/s41598-023-29273-w
PMID:36788274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9929333/
Abstract

The biomineral haemozoin, or its synthetic analogue β-haematin (βH), has been the focus of several target-based screens for activity against Plasmodium falciparum parasites. Together with the known βH crystal structure, the availability of this screening data makes the target amenable to both structure-based and ligand-based virtual screening. In this study, molecular docking and machine learning techniques, including Bayesian and support vector machine classifiers, were used in sequence to screen the in silico ChemDiv 300k Representative Compounds library for inhibitors of βH with retained activity against P. falciparum. We commercially obtained and tested a prioritised set of inhibitors and identified the coumarin and iminodipyridinopyrimidine chemotypes as potent in vitro inhibitors of βH and whole cell parasite growth.

摘要

生物矿化血红素,或其合成类似物β-血晶素(βH),一直是针对恶性疟原虫寄生虫的基于靶标的几种筛选的焦点。结合已知的βH 晶体结构,该筛选数据使该靶标易于进行基于结构和基于配体的虚拟筛选。在这项研究中,分子对接和机器学习技术,包括贝叶斯和支持向量机分类器,被连续用于筛选虚拟化学药物库 300k 代表化合物库中对 βH 具有保留活性的抑制剂,以对抗恶性疟原虫。我们商业获得并测试了一组优先抑制剂,并确定香豆素和亚氨基二吡啶嘧啶类作为βH 和整个细胞寄生虫生长的有效体外抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5f/9929333/2ecbc25fb43e/41598_2023_29273_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5f/9929333/c5f9e16e9417/41598_2023_29273_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5f/9929333/e0e227a5332e/41598_2023_29273_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5f/9929333/2ecbc25fb43e/41598_2023_29273_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5f/9929333/c5f9e16e9417/41598_2023_29273_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5f/9929333/e0e227a5332e/41598_2023_29273_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c5f/9929333/2ecbc25fb43e/41598_2023_29273_Fig3_HTML.jpg

相似文献

1
Identifying inhibitors of β-haematin formation with activity against chloroquine-resistant Plasmodium falciparum malaria parasites via virtual screening approaches.通过虚拟筛选方法识别针对耐氯喹恶性疟原虫的β-血红素形成抑制剂。
Sci Rep. 2023 Feb 14;13(1):2648. doi: 10.1038/s41598-023-29273-w.
2
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.伯氨喹或其他8-氨基喹啉用于减少恶性疟原虫传播。
Cochrane Database Syst Rev. 2015 Feb 19(2):CD008152. doi: 10.1002/14651858.CD008152.pub4.
3
Primaquine for reducing Plasmodium falciparum transmission.伯氨喹用于减少恶性疟原虫传播。
Cochrane Database Syst Rev. 2012 Sep 12(9):CD008152. doi: 10.1002/14651858.CD008152.pub2.
4
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.用于减少恶性疟原虫传播的伯氨喹或其他8-氨基喹啉类药物。
Cochrane Database Syst Rev. 2018 Feb 2;2(2):CD008152. doi: 10.1002/14651858.CD008152.pub5.
5
Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: A systematic review.在撒哈拉以南非洲国家停止使用氯喹治疗单纯性疟疾后,对氯喹耐药恶性疟原虫的分子监测:一项系统评价。
J Infect Public Health. 2022 May;15(5):550-557. doi: 10.1016/j.jiph.2022.03.015. Epub 2022 Mar 29.
6
Prevalence of molecular markers of chloroquine resistance in malaria parasites in East Africa: A systematic review and meta-analysis.东非疟原虫中氯喹耐药分子标志物的流行情况:一项系统评价与荟萃分析
J Glob Antimicrob Resist. 2025 Mar;41:117-137. doi: 10.1016/j.jgar.2024.12.019. Epub 2024 Dec 25.
7
Azithromycin for treating uncomplicated malaria.阿奇霉素用于治疗非复杂性疟疾。
Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD006688. doi: 10.1002/14651858.CD006688.pub2.
8
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.恶性疟原虫疟疾治疗中耐药性的风险——一项系统评价和荟萃分析
Parasitol Res. 2017 Feb;116(2):781-788. doi: 10.1007/s00436-016-5353-2. Epub 2016 Dec 27.
9
Rational synthesis, activity and mechanism insights of a new aminoquinoline salt against malaria parasites: in vitro and in vivo approaches.一种新型氨基喹啉盐抗疟原虫的合理合成、活性及作用机制研究:体外和体内研究方法
Chem Biol Interact. 2025 Sep 5;418:111588. doi: 10.1016/j.cbi.2025.111588. Epub 2025 Jun 4.
10
Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity.使用高通量筛选(HTS)数据训练的贝叶斯模型,用于预测β-血红素抑制和体外抗疟活性。
Bioorg Med Chem. 2015 Aug 15;23(16):5210-7. doi: 10.1016/j.bmc.2014.12.020. Epub 2014 Dec 20.

引用本文的文献

1
Impact of artificial intelligence and digital technology-based diagnostic tools for communicable and non-communicable diseases in Africa.人工智能和基于数字技术的诊断工具对非洲传染病和非传染病的影响。
Afr J Lab Med. 2024 Nov 21;13(1):2516. doi: 10.4102/ajlm.v13i1.2516. eCollection 2024.
2
Heme Detoxification in the Malaria Parasite : A Time-Dependent Basal-Level Analysis.疟原虫中的血红素解毒作用:基于时间的基础水平分析
bioRxiv. 2025 Mar 6:2025.03.06.641703. doi: 10.1101/2025.03.06.641703.
3
Towards next-generation treatment options to combat Plasmodium falciparum malaria.

本文引用的文献

1
Adsorption to the Surface of Hemozoin Crystals: Structure-Based Design and Synthesis of Amino-Phenoxazine β-Hematin Inhibitors.血晶蛋白晶体表面的吸附:基于结构的氨基吩嗪 β-血红素抑制剂的设计与合成。
ChemMedChem. 2022 May 18;17(10):e202200139. doi: 10.1002/cmdc.202200139. Epub 2022 Apr 26.
2
K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness.非洲和亚洲的 K13 突变影响青蒿素耐药性和寄生虫适应性。
Elife. 2021 Jul 19;10:e66277. doi: 10.7554/eLife.66277.
3
Coumarin-Annulated Ferrocenyl 1,3-Oxazine Derivatives Possessing In Vitro Antimalarial and Antitrypanosomal Potency.
迈向对抗恶性疟原虫疟疾的下一代治疗方案。
Nat Rev Microbiol. 2025 Mar;23(3):178-191. doi: 10.1038/s41579-024-01099-x. Epub 2024 Oct 4.
4
Novel molecular inhibitor design for Plasmodium falciparum Lactate dehydrogenase enzyme using machine learning generated library of diverse compounds.基于机器学习生成的多样化化合物库设计新型疟原虫乳酸脱氢酶分子抑制剂。
Mol Divers. 2024 Aug;28(4):2331-2344. doi: 10.1007/s11030-024-10960-3. Epub 2024 Aug 20.
香豆素并环二茂铁 1,3-恶嗪衍生物具有体外抗疟和抗锥虫活性。
Molecules. 2021 Mar 2;26(5):1333. doi: 10.3390/molecules26051333.
4
The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957.新型化学型 DDD01034957 的抗疟疗效和耐药机制。
Sci Rep. 2021 Jan 21;11(1):1888. doi: 10.1038/s41598-021-81343-z.
5
Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds.抗疟化合物的抗疟和抗疟原虫血色素活性之间的相关性。
Malar J. 2020 Aug 21;19(1):298. doi: 10.1186/s12936-020-03370-x.
6
Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery.小分子药物发现中的虚拟筛选技术增强命中鉴定。
J Chem Inf Model. 2020 Sep 28;60(9):4144-4152. doi: 10.1021/acs.jcim.0c00113. Epub 2020 May 1.
7
Virtual screening as a tool to discover new β-haematin inhibitors with activity against malaria parasites.虚拟筛选作为一种发现具有抗疟原虫活性的新型β-血红素抑制剂的工具。
Sci Rep. 2020 Feb 25;10(1):3374. doi: 10.1038/s41598-020-60221-0.
8
Antimalarial Quinoline Drugs Inhibit β-Hematin and Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition of Cysteine Proteases.抗疟喹啉类药物抑制β-血晶素并增加游离血红素,催化过氧化物反应和抑制半胱氨酸蛋白酶。
Sci Rep. 2019 Oct 28;9(1):15398. doi: 10.1038/s41598-019-51604-z.
9
Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites.抑制疟原虫血晶蛋白的 2-苯并咪唑类化合物。
Eur J Med Chem. 2018 Nov 5;159:243-254. doi: 10.1016/j.ejmech.2018.09.060. Epub 2018 Sep 28.
10
Synthesis and antiplasmodial activity of glyco-conjugate hybrids of phenylhydrazono-indolinones and glycosylated 1,2,3-triazolyl-methyl-indoline-2,3-diones.苯腙基吲哚啉酮和糖基化 1,2,3-三唑基甲基吲哚啉-2,3-二酮的糖缀合物杂合的合成及抗疟活性。
Eur J Med Chem. 2018 Jul 15;155:764-771. doi: 10.1016/j.ejmech.2018.06.042. Epub 2018 Jun 19.